文献速递消化系统肿瘤

可改变风险因素与遗传风险在胰腺癌中的年龄依赖性交互作用

Age-Dependent Interplay of Modifiable Risk Factors and Genetic Risk in Pancreatic Cancer.
PubMed 文献 · JAMA Oncol · 2026-01-01

高PRS且低MRS的<60岁人群10年标准化累积发病率低于低PRS且高MRS者。

要点

  • MRS与胰腺癌的关联在<60岁人群中最强,随年龄增长减弱。
  • PRS在各年龄段均与胰腺癌风险增加相关,交互作用不显著。
  • 高PRS人群绝对风险差最大,提示遗传高风险者更应早期干预可改变因素。

核心结论

  • 可改变风险因素与胰腺癌的关联在年轻成人中最强,尤其在高遗传风险个体中。
  • 研究提示应在生命早期启动预防,特别是高遗传风险人群。

研究设计与样本

  • 前瞻性人群队列研究,使用英国生物银行2006至2010年入组数据,中位随访11.7年。
  • 数据分析于2025年1月至9月进行。

主要发现

  • 随访期间1187名参与者(0.41%)发生胰腺癌。
  • PRS每增加1个标准差的风险比:<60岁1.39(95%CI 1.15-1.68),60-69岁1.66(95%CI 1.51-1.83),≥70岁1.37(95%CI 1.26-1.48),交互P=.43。
  • MRS每增加1分的风险比:<60岁1.69(95%CI 1.43-2.01),60-69岁1.25(95%CI 1.14-1.36),≥70岁1.20(95%CI 1.12-1.29),交互P<.001。
  • <60岁人群中,高PRS低MRS者的10年标准化累积发病率为38.2/10万人,低于低PRS高MRS者的92.2/10万人。
  • 高PRS者高与低MRS组的10年标准化累积发病率绝对差为323.1 vs 52.8/10万人,为低PRS者的6.1倍;60-69岁和≥70岁分别为1.2倍(500.1 vs 401.2/10万人)和2.8倍(851.2 vs 304.9/10万人)。

临床怎么用

  • 对年轻人群,尤其高遗传风险者,应优先评估并干预吸烟、饮酒、饮食、运动、体重、糖尿病和胰腺炎等可改变因素。
  • 可依据PRS和MRS分层识别胰腺癌高风险个体,在生命早期启动针对性预防。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Identifying individuals at higher risk of pancreatic cancer (PC) is critical for developing targeted prevention strategies. OBJECTIVE: To investigate whether the potential association of modifiable risk factors with PC varies across genetic risk profiles and age. DESIGN, SETTING, AND PARTICIPANTS: This prospective population-based cohort study used data from participants in the UK Biobank, enrolled from 2006 to 2010 and followed up for a median (IQR) of 11.7 (10.9-12.9) years. Data analysis was conducted from January to September 2025. EXPOSURES: A polygenic risk score (PRS) and a modifiable risk score (MRS; including smoking, excessive alcohol intake, unhealthy diet, physical inactivity, overweight, diabetes, and pancreatitis) for PC were each categorized as low, intermediate, and high. MAIN OUTCOMES AND MEASURES: The main outcome, incident PC, was ascertained through record linkage with national registries. Hazard ratios (HRs) were estimated to assess the individual and joint associations of the MRS and PRS with PC across age groups (<60, 60-69, and ≥70 years). Standardized 10-year cumulative incidence (SCI) per 100 000 persons was calculated according to MRS and PRS strata across age groups. RESULTS: A total of 290 645 participants (149 836 [51.6%] male; mean [SD] age, 56.1 [8.1] years) were included. During follow-up, 1187 participants (0.41%) developed incident PC. The PRS was consistently associated with increased PC risk across all age groups (HR per 1-SD increase in PRS: age <60 years, 1.39; 95% CI, 1.15-1.68; age 60-69 years, 1.66; 95% CI, 1.51-1.83; age ≥70 years, 1.37; 95% CI, 1.26-1.48; P for interaction = .43), while MRS showed stronger associations with PC in younger than older participants (HR per 1-point increase in MRS: age <60 years, 1.69; 95% CI, 1.43-2.01; age 60-69 years, 1.25; 95% CI, 1.14-1.36; age ≥70 years, 1.20; 95% CI, 1.12-1.29; P for interaction < .001). SCIs varied across combinations of PRS and MRS strata, and were higher with increasing MRS in all PRS groups. Among participants younger than 60 years, individuals with high PRS but low MRS had a lower SCI (38.2 events per 100 000 persons) than those with low PRS but high MRS (92.2 events per 100 000 persons). The absolute difference in SCIs between high and low MRS groups was greatest among individuals with high PRS, being 6.1-fold greater than that observed among those at low PRS (323.1 vs 52.8 per 100 000 persons). The corresponding fold differences were less pronounced in individuals aged 60 to 69 years and 70 years or older (1.2- and 2.8-fold; 500.1 vs 401.2 per 100 000 persons and 851.2 vs 304.9 per 100 000 persons, respectively). CONCLUSIONS AND RELEVANCE: This cohort study found that the associations of modifiable risk factors with PC were strongest among younger adults, especially those at high genetic risk. These findings highlight the importance of initiating prevention early in the life course, especially among individuals at high genetic risk.

来源:JAMA Oncol,查看原文。版权归原作者所有。

引用

  1. Ding J, Edelmann D, Carlsson SV, et al. Age-Dependent Interplay of Modifiable Risk Factors and Genetic Risk in Pancreatic Cancer. JAMA Oncol. 2026. PMID: 42133339. doi:10.1001/jamaoncol.2026.1192

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。